Semax
Synthetic heptapeptide derived from ACTH(4-10). Nootropic and neuroprotective. Elevates BDNF (brain-derived neurotrophic factor). Approved in Russia for cognitive disorders and stroke recovery.
Overview
Synthetic heptapeptide derived from ACTH(4-10). Nootropic and neuroprotective. Elevates BDNF (brain-derived neurotrophic factor). Approved in Russia for cognitive disorders and stroke recovery.
May cause slight blood pressure fluctuations. May mildly modulate cortisol (ACTH-derived but minimal HPA effect at standard doses). No significant impact on standard blood markers, hormones, lipids, or haematology.
Compound Guide
Structure: Synthetic heptapeptide analog of ACTH(4-10) fragment with a Pro-Gly-Pro C-terminal extension for stability. Nootropic with neuroprotective properties.
Dosage:
- Cognitive enhancement: 200-600mcg/day intranasal or SubQ
- Standard SubQ: 500mcg-1mg/day for 4-8 weeks
- Intensive (post-stroke, clinical): up to 6mg/day for 10-day courses
Administration:
- Intranasal (nasal spray) is the traditional Russian administration method
- SubQ injection is also effective
- Morning dosing preferred — may cause restlessness if taken late
Key Notes:
- Increases BDNF (brain-derived neurotrophic factor) — promotes neuroplasticity, learning, and memory
- Approved pharmaceutical in Russia (as nasal drops) for cognitive dysfunction and stroke recovery
- Neuroprotective: may protect against oxidative stress and neurotoxicity
- No addiction potential or tolerance — safe for extended use
- Bodybuilding relevance: cognitive focus during training, recovery from brain fog (e.g., Trenbolone-related cognitive sides), stress resilience
- Stimulatory but not anxiogenic — provides clean mental energy without jitteriness
- N-Acetyl Semax Amidate (NASA) is a modified version with enhanced potency and duration
- Monitor: blood pressure (mild fluctuations possible)
Usage History
Frequently Asked Questions
Quick Reference
Category
Peptide
Half-Life
~30 seconds - 5 minutes (rapid onset, effects last hours)
Detection Time
N/A